리스템

비상장

LISTEM CORPORATION

문창호

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

리스템

Business Reg. No. 3058109002 · CEO 문창호

I.Investment Overview

Target리스템 (3058109002)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명리스템
영문명LISTEM CORPORATION
대표자문창호
사업자등록번호3058109002
법인등록번호1641110000454
설립일1985.09.24
종업원수62명

V.Workforce

62

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW119.22021130.4202285.1202372.6202451.72025
영업이익100M KRW9.52021102022-28.82025
순이익100M KRW4.920216.920220.1202314.82024-27.52025
Item20252024202320222021
자산총계236억원265.4억원252.2억원256.3억원238.2억원
부채총계105.7억원107.6억원109.2억원113.3억원102.2억원
자본총계130.3억원157.8억원143억원143억원136억원
매출액51.7억원72.6억원85.1억원130.4억원119.2억원
영업이익-28.8억원10억원9.5억원
순이익-27.5억원14.8억원503만원6.9억원4.9억원

VII.Financial Ratios

FY2025 basis

-55.7%

영업이익률

-53.2%

순이익률

-11.65%

ROA

-21.1%

ROE

81.08%

부채비율

55.22%

자기자본비율

VIII.R&D Activity

Fields 보건의료 > 의료기기 · 전기/전자 > 기타 전기/전자

Keywords 디지털, 엑스선, 제너레이터, 디텍터, 영상 재구성

YearProjectsPapersPatents
2023101
2022102
2021100
2020201
2019101
2018104
20172184
2016233
2015104
2014140
2013236
2012200
2011100
2010200

IX.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

리스템 투심보고서 | Alpha Lenz